A Common Sense Framework for 401(k), 403(b), CIT, and Target-Date Fund Fiduciaries

Introduction
Private equity and other private-market investments are increasingly being pushed into participant-directed retirement plans through target-date funds, CITs, interval funds, evergreen vehicles, and semi-liquid wrappers. Fiduciaries are often told these products provide “diversification,” “institutional access,” and “enhanced returns.”
However, private equity products differ fundamentally from traditional mutual funds and public securities. They involve limited transparency, subjective valuation, conditional liquidity, complex fee structures, leverage, and performance reporting methodologies that are often not comparable to public-market investments.
Oxford Professor Ludovic Phalippou recently warned the Department of Labor that “asset neutrality should not mean metric neutrality, disclosure neutrality, or governance neutrality.”https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6847259
This checklist is designed to help ERISA fiduciaries identify hidden risks, conflicts, prohibited transaction concerns, and misleading performance claims before adding private-market exposure to participant-directed retirement plans.
I. Performance Measurement & Benchmarking
□ 1. Avoid reliance on IRR as the primary performance metric
Internal Rate of Return (“IRR”) is not equivalent to mutual fund or index returns and does not measure investor wealth compounding. IRR is heavily influenced by cash-flow timing, subscription lines, early exits, dividend recapitalizations, and leverage.
Professor Phalippou notes that private equity firms such as KKR and Apollo have reported remarkably stable since-inception IRRs for decades, despite radically different market conditions, demonstrating how IRR can become mathematically “sticky” rather than economically meaningful.
Fiduciary Questions
- Is IRR being compared directly to public market annualized returns?
- Is IRR being used to justify superiority over index funds?
- Are subscription credit lines artificially inflating IRR?
- Is the fiduciary receiving actual cash-flow-based investor outcome analysis?
□ 2. Require Public Market Equivalent (PME) analysis
Fiduciaries should require cash-flow-based PME benchmarking rather than marketing-based IRR comparisons.
PME analysis should:
- Be specified ex ante
- Match geography, leverage, sector, currency, and risk
- Be net of all fees and expenses
- Compare against realistic investable alternatives
Fiduciary Questions
- Was the benchmark selected before evaluating performance?
- Is the benchmark investable and liquid?
- Does the benchmark reflect similar leverage and sector exposure?
- Is the comparison apples-to-apples?
□ 3. Compare the entire target-date product—not merely the private sleeve
Private equity allocations are frequently embedded inside target-date funds, collective investment trusts, or multi-layered structures.
The relevant fiduciary question is not:
“Did the private sleeve outperform?”
The relevant question is:
“Did the total participant product improve expected participant outcomes after all fees, liquidity limits, valuation risk, leverage, and complexity?”
Fiduciary Questions
- Would a simple public-market implementation likely achieve similar outcomes?
- Is the private sleeve adding measurable participant value after all costs?
- Is volatility being artificially suppressed through stale or subjective valuations?
II. Fee Transparency & Hidden Compensation
□ 4. Require consolidated all-in fee disclosure
Private equity fees frequently extend far beyond “2 and 20.”
Potential hidden costs include:
- Portfolio-company monitoring fees
- Transaction fees
- Financing fees
- Broken-deal expenses
- Advisory fees
- Platform fees
- Subscription-line costs
- Distribution compensation
- Affiliate payments
- Feeder fund expenses
- Consulting and placement fees
Professor Phalippou emphasizes that “knowing fees are 2%-20%-8% does not convey the actual economic burden.”
Fiduciary Questions
- What percentage of gross investment gain is ultimately retained by participants?
- Are affiliate payments fully disclosed?
- Are portfolio-company fees rebated or retained?
- Is compensation flowing to parties in interest?
□ 5. Examine revenue-sharing and platform conflicts
Private-market products often generate indirect compensation to:
- Recordkeepers
- Consultants
- OCIO providers
- Target-date managers
- Placement agents
- Wealth platforms
- CIT trustees
Fiduciary Questions
- Does any service provider receive compensation tied to private-market allocations?
- Are fiduciaries receiving fully transparent compensation reports?
- Are private-market products steering participants toward higher-fee structures?
III. Valuation, NAV, and Fair Pricing
□ 6. Scrutinize NAV-based pricing mechanisms
Many semi-liquid and evergreen structures use Net Asset Value (“NAV”) as:
- Subscription pricing
- Redemption pricing
- Fee calculation basis
- Performance reporting basis
This creates substantial conflicts when valuations are subjective.
Professor Phalippou notes that investors may subscribe or redeem at prices materially disconnected from actual market-clearing values.
Fiduciary Questions
- Are secondary market discounts materially below stated NAV?
- Who determines the NAV?
- Can the manager influence valuation inputs?
- Are stale marks suppressing volatility?
□ 7. Evaluate continuation funds and affiliated transactions
Continuation vehicles, GP-led secondaries, and cross-fund sales create inherent conflicts where the manager may influence both price and process.
Fiduciary Questions
- Are fairness opinions truly independent?
- Does the manager control both sides of the transaction?
- Are participants effectively buying marked-up assets from affiliated entities?
IV. Liquidity & Stress Testing
□ 8. Conduct stress-based liquidity analysis
Quarterly liquidity windows, gates, redemption caps, and side pockets may function normally during stable markets but fail during stressed conditions.
Fiduciary Questions
- What occurs during mass participant withdrawals?
- What happens if public markets decline sharply?
- How would the product behave during a plan termination or sponsor bankruptcy?
- Could remaining participants become trapped in illiquid assets?
□ 9. Analyze first-mover advantage risk
Semi-liquid structures may reward early redeemers while leaving remaining participants with concentrated illiquid exposure.
Fiduciary Questions
- Are liquid assets sold first during redemption stress?
- Does the portfolio become progressively riskier after withdrawals?
- Could later participants bear disproportionate valuation losses?
V. Complexity & Governance Risk
□ 10. Treat complexity itself as a fiduciary risk factor
Complexity is not merely operational—it can conceal:
- Hidden fees
- Affiliate conflicts
- Leverage
- Valuation manipulation
- Benchmark gaming
- Illiquidity
- Risk concentration
Fiduciary Questions
- Can participants reasonably understand the structure?
- Can fiduciaries independently evaluate the underlying holdings?
- Does complexity benefit participants—or intermediaries?
□ 11. Investigate consultant and adviser conflicts
Professor Phalippou specifically warns that adviser reliance should not substitute for fiduciary judgment.
Many consultants, OCIO providers, and recordkeepers have economic incentives aligned with expanding private-market usage. Many consultants are owned by Private Equity https://commonsense401kproject.com/2026/05/09/consultants-conflicts-and-the-collapse-of-public-pension-performance/
Fiduciary Questions
- Does the consultant receive compensation from private-market sponsors?
- Does the adviser manage affiliated CITs or private products?
- Are fiduciaries independently verifying consultant recommendations?
VI. Prohibited Transaction & ERISA Concerns
□ 12. Investigate party-in-interest relationships
Private-market structures frequently involve overlapping financial relationships among:
- Recordkeepers
- Consultants
- CIT trustees
- Insurance companies
- OCIO providers
- Placement agents
- Asset managers
Fiduciary Questions
- Are fiduciaries causing plans to transact with parties in interest?
- Are affiliates receiving indirect compensation?
- Could the structure implicate ERISA §§406(a) or 406(b)?
□ 13. Evaluate whether “availability” is being sold rather than prudence
Higher-fee products are often justified based on “access” or “institutional availability,” even where comparable public-market exposure exists at dramatically lower cost and greater transparency.
Fiduciary Questions
- Is private-market exposure truly necessary?
- Would public-market alternatives likely provide similar participant outcomes?
- Is illiquidity being confused with sophistication?
VII. Common Sense Participant Protection Questions
Before adding private equity exposure, fiduciaries should ask:
- Would I fully explain this structure to participants in plain English?
- Could participants independently verify valuation and performance claims?
- Could participants easily understand total fees?
- Would the product remain attractive if fully transparent?
- Is the structure designed primarily for participant benefit—or intermediary profit extraction?
Conclusion
Private equity is not automatically prudent or imprudent under ERISA. But private-market products require significantly greater scrutiny because they involve:
- subjective valuation,
- conditional liquidity,
- opaque fee structures,
- benchmark manipulation risk,
- leverage,
- and substantial conflicts of interest.
As Professor Ludovic Phalippou recently warned the Department of Labor, fiduciaries must distinguish “asset neutrality” from “metric neutrality, disclosure neutrality, and governance neutrality.”
ERISA fiduciaries should not treat private-market products as ordinary mutual funds merely because they are packaged inside a target-date fund, CIT, or retirement wrapper.
Retirement savers deserve transparent pricing, meaningful benchmarking, stress-tested liquidity, fair valuation practices, and fully disclosed conflicts before their retirement savings are exposed to private-market risk.







